Importancia de la monitorización continua de glucosa en el control de la diabetes mellitus tipo 1

The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-86. 1998, Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complicatons in patients with type 2 diabetes, Lancet, 352, 837, 10.1016/S0140-6736(98)07019-6 1998, Standards of medical care for patients with diabetes mellitus, Diabetes Care, 21, S23 Garg, 2006, Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial, Diabetes Care, 29, 44, 10.2337/diacare.29.01.06.dc05-1686 Boland, 2001, Limitations of conventional methods of self monitoring of blood glucose, Diabetes Care, 24, 1858, 10.2337/diacare.24.11.1858 Summary of safety and effectiveness data for the MiniMed Continuous Glucose Monitoring System (CGMS). PMA P980022 [publicación electrónica]. Washington: Food and Drug Administration; 1999. Disponible en: http://www.fda.gov/cdrh/pdf/p980022.html Gross, 2000, Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use, Diabetes Technol Ther, 2, 49, 10.1089/152091500316737 Mastrototaro, 1999, The MiniMed Continuous Glucose Monitoring System (CGMS), J Pediatr Endocrinol Metab, 12, 751 Rebrin, 1999, Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous montoring, Am J Physiol, 277, E561 Schmidt, 1993, Glucose concentration in subcutaneous extracellular space, Diabetes Care, 16, 695, 10.2337/diacare.16.5.695 Sternberg, 1995, Subcutaneous glucose concentration in humans: real estimation and continuous monitoring, Diabetes Care, 18, 1266, 10.2337/diacare.18.9.1266 Bode, 2000, Continuous glucose monitoring facilitates sustainable improvements in glycemic control [resumen], Diabetes, 49, A393 Bode, 2000, Clinical decision making: new opportunities for therapeutic changes with continuous glucose sensing, Diabetes Spectrum, 13, 171 Deiss, 2004, Assessment of glycemic control by continuous glucose monitoring system in 50 children with type 1 diabetes starting on insulin pump therapy, Pediatr Diabetes, 5, 117, 10.1111/j.1399-543X.2004.00053.x López-Siguero, 2003, Monitorización continua de glucosa en la diabetes mellitus tipo 1, An Pediatr (Barc), 58, 217, 10.1157/13043552 Jamali, 2005, Continuous glucose monitoring system signals the occurrence of marked postprandial hyperglycemia in the elderly, Diabetes Technol Ther, 7, 509, 10.1089/dia.2005.7.509 Kaufman, 2001, A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic patients, Diabetes Care, 24, 2030, 10.2337/diacare.24.12.2030 Chico, 2003, The continuos glucose monitoring system in useful for detecting unrecognized hypoglycemias in patients with type1 and type 2 diabetes but is not better than frecuent capillary glucose measurements for improving metabolic control, Diabetes Care, 26, 1153, 10.2337/diacare.26.4.1153 Bolli, 1993, Nocturnal blood glucose control in type 1 diabetes mellitus [revisión], Diabetes Care, 16, 71, 10.2337/diacare.16.3.71 Gross, 2000, Detection of unseen hypoglycemia using continous glucose monitoring [resumen], Diabetologia, 43, A790 Cheyne, 2000, Making sense of type 1 diabetes: unrecognized hypoglycemia during continous glucose sensing [resumen], Diabetologia, 43, A790 Hoi-Hansen, 2005, Reproducibility and reliability of hypoglycaemic episodes recorded with Continuous Glucose Monitoring System (CGMS) in daily life, Diabet Med, 22, 858, 10.1111/j.1464-5491.2005.01552.x Larsen, 2004, What is hypoglycemia in patients with well-controlled type 1 diabetes treated by subcutaneous insulin pump with use of the continuous glucose monitoring system?, Endocr Pract, 10, 324, 10.4158/EP.10.4.324 Von Dobeln, 2005, Nocturnal differences in subcutaneous tissue glucose between forearm and abdominal sites during continuous glucose monitoring in normal subjects, Diabetes Metab, 31, 347, 10.1016/S1262-3636(07)70203-3 Chase, 2001, Continuous subcutaneouos glucose monitoring in children with type 1 diabetes, Pediatrics, 107, 222, 10.1542/peds.107.2.222 Glowinska-Olszewska, 2005, [Usefulness of continuous glucose monitoring system (CGMS) in monitoring glycaemic profile in small children with diabetes type 1], Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw, 11, 237 McDonnell, 2005, A novel approach to continuous glucose analysis utilizing glycemic variation, Diabetes Technol Ther, 7, 253, 10.1089/dia.2005.7.253 Micak, 2004, A continuous glucose monitoring system (CGMS) - a promising approach for improving metabolic control in persons with type 1 Diabetes mellitus treated by insulin pumps, Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 148, 33, 10.5507/bp.2004.005 Schaepelynck-belicar, 2003, Improved metabolic control in diabetic adolescents using the continuous glucose monitoring system (CGMS), Diabetes Metab, 29, 608, 10.1016/S1262-3636(07)70076-9 Salardi, 2002, The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA1c in pediatric type 1 diabetic patients, Diabetes Care, 25, 1840, 10.2337/diacare.25.10.1840 Tanenberg, 2004, Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial, Mayo Clin Proc, 79, 1521, 10.4065/79.12.1521 Kubiak, 2004, Assessment of hypoglycaemia awareness using continuous glucose monitoring, Diabet Med, 21, 487, 10.1111/j.1464-5491.2004.1136.x Tavris, 2004, The public health impact of the Mini-Med Continuous glucose Monitoring System (CGMS) –an assessment of the literature, Diabetes Technol Ther, 4, 518, 10.1089/1520915041705956